PMID- 15100507 OWN - NLM STAT- MEDLINE DCOM- 20041130 LR - 20191210 IS - 0143-3636 (Print) IS - 0143-3636 (Linking) VI - 25 IP - 5 DP - 2004 May TI - Detection of stent restenosis in single vessel CAD: comparison of 201Tl and gated 99mTc-MIBI SPECT. PG - 479-86 AB - BACKGROUND AND AIM: After successful percutaneous transluminal coronary angioplasty (PTCA), stent restenosis is observed in up to 40% of patients during the first year. The aim of this study was to determine the value of myocardial perfusion studies (MPSs) in the detection of stent restenosis in a symptomatic patient cohort. METHODS: A total of 80 patients without prior myocardial infarction (MI) and who underwent one-vessel PTCA with stent implantation were included to study. The diagnostic accuracy of two study protocols, Tl single photon emission computed tomography (SPECT) (38 patients) and rest-stress same day gated Tc sestamibi (MIBI) SPECT (42 patients), were compared. MPS data were visually evaluated by two experienced observers and stress induced perfusion defects with reversibility at rest was considered as restenosis. In gated MIBI data the wall motion (WM) and ejection fraction (EF) were also noted. The diagnostic value of a semiquantitative method based on 20 segment model and summed stress scores (SSSs) and summed difference scores (SDSs) were also tested. Results of MPSs were compared with control coronary angiography (CA) in all patients and agreement was defined as the kappa value (kappa). RESULTS: The average time between stent implantation and MPS was 8.9 +/- 2 months. Restenosis was detected in 58% of patients in CA. No significant differences were observed regarding age, gender, achieved exercise levels, vascular territorial distribution of lesions, imaging time interval after PTCA and degree of restenosis between Tl and gated MIBI groups. MPSs identified stent restenosis in 41 of 47 patients (sensitivity, 87%; specificity, 82%; accuracy, 85%; kappa=0.69). Four of six occluded stents that could not be detected in MPSs revealed intermediate degree stenosis (50-70%). Sensitivity, specificity and accuracy were not significantly different but better for gated MIBI group when compared to Tl (sensitivity, 90-83%; specificity, 85-80%; accuracy, 88-82%). Semiquantitative evaluation using SSS and SDS reached lower sensitivity than qualitative evaluation (MIBI, 90% vs 69%; Tl, 83% vs 72%) but higher specificity (MIBI, 85% vs 92%; Tl, 80% vs 100%) for both tracers and SSS were significantly correlated with occlusion degree (r=0.69). EF values calculated from the gated MIBI study were also inversely correlated with occlusion degree (r=0.55) and significantly different in patients with occluded stents (P<0.001). Agreement with CA for both tests were adequate (kappa=0.73, for MIBI; and kappa=0.63, for Tl). CONCLUSION: Semiquantitative evaluation of MPSs using SSS may enhance diagnostic specificity in the detection of stent restenosis. Both Tl and gated MIBI studies accurately detected stent restenosis. The gated MIBI method has advantages of WM analysis and evaluation of EF. FAU - Cingi, Elif AU - Cingi E AD - Department of Nuclear Medicine, Faculty of Medicine, Gazi University, Besevler, 06510 Ankara, Turkey. FAU - Temiz, Nuh Hakan AU - Temiz NH FAU - Yildirim, Nilufer AU - Yildirim N FAU - Timurkaynak, Timur AU - Timurkaynak T FAU - Cengel, Atiye AU - Cengel A FAU - Unlu, Mustafa AU - Unlu M LA - eng PT - Clinical Trial PT - Comparative Study PT - Controlled Clinical Trial PT - Journal Article PT - Validation Study PL - England TA - Nucl Med Commun JT - Nuclear medicine communications JID - 8201017 RN - 0 (Radiopharmaceuticals) RN - 37CB58V15B (thallium chloride) RN - 971Z4W1S09 (Technetium Tc 99m Sestamibi) RN - AD84R52XLF (Thallium) SB - IM MH - Adult MH - Aged MH - Angioplasty, Balloon, Coronary/*adverse effects MH - Blood Vessel Prosthesis/*adverse effects MH - Cohort Studies MH - Coronary Artery Disease/complications/*surgery MH - Female MH - Gated Blood-Pool Imaging/methods MH - Graft Occlusion, Vascular/*diagnostic imaging/etiology MH - Humans MH - Male MH - Middle Aged MH - Prognosis MH - Radiopharmaceuticals MH - Reproducibility of Results MH - Sensitivity and Specificity MH - Stents/*adverse effects MH - *Technetium Tc 99m Sestamibi MH - *Thallium MH - Tomography, Emission-Computed, Single-Photon/methods EDAT- 2004/04/22 05:00 MHDA- 2004/12/16 09:00 CRDT- 2004/04/22 05:00 PHST- 2004/04/22 05:00 [pubmed] PHST- 2004/12/16 09:00 [medline] PHST- 2004/04/22 05:00 [entrez] AID - 00006231-200405000-00009 [pii] AID - 10.1097/00006231-200405000-00009 [doi] PST - ppublish SO - Nucl Med Commun. 2004 May;25(5):479-86. doi: 10.1097/00006231-200405000-00009.